Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag

Watch time: 12m 38s
AHA 22: Efficacy of Empagliflozin in Black vs White Pts With Heart Failure

Subodh Verma

Watch time: 5m
Radcliffe & CardioNerds @AHA22: IRONMAN: Intravenous Ferric Derisomaltose in HF With Reduced EF

Rawan Amir, Paul Kalra

Watch time: 18m 58s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill

Watch time: 5m 44s
HFSA 22: Heart Failure Recognition with Micro Electro-mechanical Sensors

Watch time: 7m 55s
Radcliffe & CardioNerds @AHA22: The ECMO-CS Trial

Petr Ostadal, Saahil A Jumkhawala

Watch time: 13m 45s

Broadcast

Electrophysiology & Arrhythmia

Heart Failure
What's Hot at AHA22? Top 10 Late-breaking Science Trials

Joost Daemen, Nicolas M Van Mieghem,

Watch time: 35m 25s
View from the Thoraxcenter: AHA 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 35m 25s

Broadcast

Heart Failure
Hyperkalaemia in Cardiorenal Disease

Shelley Zieroth, Clara Bonanad Lozano, Andrew Frankel , et al

Watch time: 1h 34m 52s

Alexandre Mebazaa, Harriette Van Spall

Watch time: 21m 14s
Radcliffe & CardioNerds @AHA22: EMPA-Kidney: Empagliflozin & CV Outcomes in Patients with Chronic Kidney Disease

Kate Wilcox, David Preiss

Watch time: 18m 1s
Insights from EMPA-Kidney: Methodology, Data & Impact

Kate Wilcox, David Preiss

Watch time: 38m 47s
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial

Julian Gillmore

Watch time: 8m 12s
AHA 22: Late-Breaker Discussion: The TRANSFORM-HF Trial

Harriette Van Spall, Robert Mentz

Watch time: 13m 29s

Paul Kalra

Watch time: 12m 41s (2 videos)

Joseph A Hill, Mirvat Alasnag

Watch time: 5h 4m 36s (26 videos)